# Hôpital Necker-Enfants Malades

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/hopital-necker-enfants-malades/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 75.6 |
| Citations | 3,727,974 |
| City | Paris |
| Country | FR |
| Description | Hôpital Necker-Enfants Malades is a research organisation in Paris, FR. OpenAlex records 35,450 works and 3,727,974 citations for it. 5,830 researchers list it as their most recent affiliation. |
| Homepage | http://hopital-necker.aphp.fr/ |
| OpenAlex ID | https://openalex.org/I1288880153 |
| Region | Île-de-France |
| Researchers | 5,830 |
| ROR ID | https://ror.org/05tr67282 |
| Type | healthcare |
| Works | 35,450 |

## University papers

Showing 12 of 155.

- [Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling](https://scholariq.org/papers/distinct-types-of-diffuse-large-b-cell-lymphoma-identified-by-gene-expression/)
- [<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1](https://scholariq.org/papers/i-lmo2-i-associated-clonal-t-cell-proliferation-in-two-patients-after-gene/)
- [Autoantibodies against type I IFNs in patients with life-threatening COVID-19](https://scholariq.org/papers/autoantibodies-against-type-i-ifns-in-patients-with-life-threatening-covid-19/)
- [Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.](https://scholariq.org/papers/rituximab-chimeric-anti-cd20-monoclonal-antibody-therapy-for-relapsed-indolent/)
- [Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome](https://scholariq.org/papers/trial-of-cannabidiol-for-drug-resistant-seizures-in-the-dravet-syndrome/)
- [Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference](https://scholariq.org/papers/tuberous-sclerosis-complex-diagnostic-criteria-update-recommendations-of-the/)
- [Enteral Nutrient Supply for Preterm Infants: Commentary From the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition](https://scholariq.org/papers/enteral-nutrient-supply-for-preterm-infants-commentary-from-the-european-society/)
- [Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study](https://scholariq.org/papers/lymphoproliferative-disorders-in-patients-receiving-thiopurines-for-inflammatory/)
- [Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes](https://scholariq.org/papers/insulin-needs-after-cd3-antibody-therapy-in-new-onset-type-1-diabetes/)
- [International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: Position paper by the ILAE Task Force on Nosology and Definitions](https://scholariq.org/papers/international-league-against-epilepsy-classification-and-definition-of-epilepsy/)
- [Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma](https://scholariq.org/papers/somatic-and-germline-activating-mutations-of-the-alk-kinase-receptor-in/)
- [Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study](https://scholariq.org/papers/neurodevelopmental-disabilities-and-special-care-of-5-year-old-children-born/)

## University researchers

- [Rima Nabbout](https://scholariq.org/researchers/rima-nabbout/)
- [Dominique Joly](https://scholariq.org/researchers/dominique-joly/)
- [S. Poirée](https://scholariq.org/researchers/s-poiree/)
- [Cécile Lambe](https://scholariq.org/researchers/cecile-lambe/)

## University top topics

Showing 8 of 25.

- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Metabolism and Genetic Disorders](https://scholariq.org/topics/metabolism-and-genetic-disorders/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Congenital Heart Disease Studies](https://scholariq.org/topics/congenital-heart-disease-studies/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.